Gerber Kawasaki's co-founder Ross Gerber has dismissed the launch of an affordable Tesla Inc. (NASDAQ:TSLA) Model Y trim level as speculation takes over ahead of the October 7 event.Check out the price of TSLA here.‘It's Really Sad," Says Ross GerberTaking to the social media platform X on Monday, Gerber shared his thoughts in a post following a teaser released by Elon Musk's company. "Please not another model Y thats less good for less money. It’s really sad," Gerber said, expressing his disappointment wit ...

Core Insights - The article discusses the comparative investment potential of XRP and BNB, emphasizing that crypto assets that expand their total addressable market (TAM) tend to appreciate in value more effectively than those that focus solely on existing markets [1]. XRP Overview - XRP was designed by Ripple primarily as a payments and asset-settlement cryptocurrency, targeting financial institutions such as banks and currency exchange houses [3]. - The XRP Ledger (XRPL) features compliance-friendly functionalities that allow asset issuers to meet regulatory requirements without relying on third-party smart contracts, which is crucial for institutions concerned about legal liabilities [4]. - Transaction costs on the XRPL are minimal and predictable, which is essential for high-volume money transfers, and it offers rapid transaction settlement times, reducing the need for businesses to tie up working capital [5]. - Ripple is actively exploring new markets for XRP, leveraging its strong reputation to attract major financial companies for trial programs, which could lead to increased capital inflows if successful [6][7]. - The investment thesis for XRP hinges on Ripple's ability to execute its strategy effectively, expanding the range of financial services and attracting a broader user base, thereby enhancing the network's value [8]. BNB Overview - BNB aims to serve as a valuable native token for the Binance crypto exchange, positioning itself within the cryptocurrency ecosystem [8]. - Both XRP and BNB are focused on financial use cases, but XRP's broader goal encompasses a wider array of financial tools and capabilities compared to BNB [8]. - XRP faces significant competition from other cryptocurrencies and traditional fintech companies as it seeks to expand its market presence [9].

Future Fund LLC's managing director, Gary Black, thinks a new approach for Tesla Inc.'s (NASDAQ: TSLA) Robotaxi valuation would work better amid the Robotaxi push in the U.S.Tesla's Valuation Needs A TAM And Market Share-Based ApproachSharing his thoughts on the social media platform X on Wednesday, the investor said that he believes the EV giant will achieve unsupervised autonomy but warns, "so will a handful of others."He then said that a total addressable market (TAM) and market share approach is needed ...

Core Insights - The current investment landscape presents opportunities for growth investors despite market volatility, facilitated by modern brokerages that provide access to a wide range of global stocks [1] Group 1: Strategic Reviews and Resets - Companies undergoing strategic reviews can reposition themselves for sustainable growth by focusing on high-potential areas and exiting unprofitable segments [3] - Hongkong Land Holdings announced a strategic review in October, planning to exit the build-to-sell property segment and focus on integrated commercial developments to generate steady income [4] - Singtel has been executing a strategic reset since May 2021, aiming to capitalize on 5G opportunities and improve return on invested capital (ROIC), targeting low double-digit ROIC by fiscal 2026 [5][6] Group 2: Sustainable Trends and Catalysts - Identifying sustainable trends, such as the rise of athleisure, can uncover promising growth stocks, exemplified by Lululemon's revenue growth from US$8.1 billion in fiscal 2023 to US$10.6 billion in fiscal 2025 [9][10] - Mercadolibre's revenue surged from US$10.8 billion in 2022 to US$20.8 billion in 2024, driven by the e-commerce market's projected 19% CAGR from 2022 to 2027 [11] - Coupang's revenue increased from US$20.6 billion in 2022 to US$30.3 billion in 2024, achieving profitability in 2023 with US$1.4 billion in net income [12] Group 3: Large Total Addressable Market (TAM) - Companies with a large TAM, such as ResMed, which aims to serve 500 million people by 2030, present significant long-term growth potential [13][14] - Dexcom targets a growing market for continuous glucose monitoring, with only 5% penetration among Type 2 diabetics not on insulin, indicating substantial room for expansion [15] Group 4: Successful Serial Acquirers - Companies like Hawkins have successfully executed multiple acquisitions, resulting in revenue growth from approximately US$935 million in fiscal 2023 to over US$974 million in fiscal 2025 [18] - Rollins, a pest control company, added 24 businesses through acquisitions in 2023 and 32 in 2024, leading to revenue growth from US$2.7 billion in 2022 to US$3.4 billion in 2024 [19][20]

Core Viewpoint - CrowdStrike Holdings Inc. has experienced a decline of 9.76% in the last 30 trading days, yet it remains one of the best-performing technology stocks in the S&P 500 with a 79% increase in 2025, following a year-long rally initiated by effective damage control after a software outage [1][2]. Financial Performance - The company reported $194 million in new net annual recurring revenue (ARR) for the first quarter of its 2026 fiscal year, a critical metric for cybersecurity firms indicating year-over-year revenue retention [7]. - CrowdStrike achieved its first $1 billion in quarterly revenue recently, indicating a market share of under 5% in its core cybersecurity market, which is projected to be $103 billion [10][14]. - The forward price-to-earnings (P/E) ratio stands at 771x, influenced by negative GAAP earnings of 44 cents in the last quarter due to high stock-based compensation [11][13]. Market Outlook - The total addressable market (TAM) for AI-native cybersecurity platforms is estimated at $116 billion for the current year, expected to grow to $250 billion by 2029 [9]. - CrowdStrike's guidance suggests a potential to generate over $1.3 billion in adjusted operating profit for FY2026, making its forward multiple appear reasonable on a non-GAAP basis [13]. Product Development - The company is expanding its AI-native Falcon platform, which is utilized by approximately 92% of Fortune 500 companies in various business areas [4]. - Recent launches include AI Systems Security Assessment and AI for SecOps Readiness, aimed at securing AI systems and integrating AI into security operations [6]. Stock Performance and Technical Analysis - CrowdStrike stock has lost bullish momentum, crossing below its 50-day simple moving average, with an RSI around 36 indicating potential for a trend reversal with strong earnings [15]. - Resistance is noted at $475, with support levels around $400 and a significant buying opportunity around $375 to $380 if the stock declines further [16].

Financial Performance & Growth - Total revenue has grown consistently, with FY25 reaching $1595 million and a projected $1715 million for FY26 [9] - The company anticipates a 12% year-over-year (YoY) growth in total revenue [9] - Adjusted EBITDA shows increasing profitability, reaching $583 million in FY25 and a projected $614 million in FY26 [9] - The company has successfully driven approximately 400 basis points of Adjusted EBITDA margin leverage since FY23 [57] - Free Cash Flow (FCF) also demonstrates leverage, reaching $219 million in FY25 [59] Market & Product Strategy - The company estimates a Realized HCM Total Addressable Market (TAM) of approximately $22 billion [12] - The company has penetrated approximately 3% of its addressable market [13] - Over 25% of new client revenue comes from referrals from channels [46] - The company has over 92% net revenue retention as a public company [47] - Total Non-GAAP R&D investment has increased to $227 million in FY25 [24]

Core Insights - 60 Degrees Pharmaceuticals has identified a total addressable market (TAM) for ARAKODA (tafenoquine) in treating human babesiosis, estimating it at 380,000 patients and $245 million in annual sales, with a cumulative TAM of 1.17 million patients and $1.1 billion through patent expiration in 2035 [1][2][8] - The company is advancing clinical research for tafenoquine to address the unmet medical need for babesiosis, a serious tick-borne illness, with no FDA-approved treatments currently available [1][3] Market Research - The TAM calculations were based on a nationwide survey of 6,000 patients and a quantitative research survey of 300 healthcare professionals conducted by Format Analytics [2][8] Clinical Trials - Three clinical trials sponsored by 60 Degrees Pharmaceuticals are underway to evaluate the safety and efficacy of tafenoquine for treating babesiosis, with data expected in the first half of 2026 [4][8] - A New Drug Application (NDA) submission to the U.S. FDA for babesiosis is anticipated in 2026, contingent on positive trial results [4][8] Product Information - ARAKODA (tafenoquine) was approved for malaria prophylaxis in the U.S. in 2018 and launched commercially in 2019, with a long terminal half-life of approximately 16 days allowing for less frequent dosing [5][6] - Tafenoquine is not currently approved for the treatment or prevention of babesiosis [6] Company Overview - 60 Degrees Pharmaceuticals, founded in 2010, focuses on developing new medicines for infectious diseases and has received FDA approval for ARAKODA for malaria prevention [17]

Financial Performance & Growth - Total revenue has grown significantly over the past few years, from $853 million in FY22 to $1,583 million in FY25 (guidance)[9] - Adjusted EBITDA has also increased substantially, from $238 million in FY22 to $573 million in FY25 (guidance)[9] - The company targets long-term adjusted EBITDA margins of 35-40% and free cash flow margins of 20-25%[58] - Free cash flow has increased from $87 million in FY21 to $306 million in FY24[64] - Recurring and other revenue has grown consistently, reaching $1,463 million in FY25 (guidance), representing a 14% year-over-year growth[56] Market & Strategy - The company estimates a realized HCM total addressable market (TAM) of approximately $19.5 billion[12] - The company has penetrated approximately 3% of its addressable market[13] - The company focuses on a target market of roughly 1.3 million businesses with 10-5,000 employees[19] - Over 25% of new client revenue comes from referrals from channels[45] - The company maintains a net revenue retention rate of over 92%[51, 52]

Company Overview - American Express has been experiencing robust top-line growth since the pandemic, although this growth has moderated somewhat over the past year. The company is still targeting growth above historical levels, aiming for an increase of 8% to 10% in the coming years [5]. Growth Outlook - The total addressable market (TAM) for American Express is estimated to be growing at approximately 6% to 7%. This growth is driven by a combination of U.S. GDP growth and inflation, with international markets growing at a faster rate due to greater cash conversion to credit opportunities [6].

Boot Barn (BOOT) FY Conference Summary Company Overview - Boot Barn is a retail brand established in 1978, focusing on Western, work, and everyday lifestyle products [3][2] - The company has expanded its store base significantly over the years and has a strong exclusive brand portfolio [3][2] Total Addressable Market (TAM) - Initial TAM at IPO was $20 billion, primarily from work and Western customers [4] - Expansion of TAM to $40 billion by including the "Just Country" customer segment, adding approximately $15 billion [7][8] Competitive Landscape - Boot Barn operates 467 stores, with competition from regional players like Cavenders (104 stores) and various mom-and-pop retailers [8][9] - The industry is characterized by rational pricing strategies, avoiding price wars common in other retail sectors [12] Financial Performance - FY 2025 sales increased by 15% to $1.9 billion, with comparable sales up 5.5% [13] - Earnings per share (EPS) reached $5.88, nearly three times higher than four years ago [13] - Historical same-store sales growth averaged 5.5%, with a significant post-COVID spike of 54% [14][15] Store Expansion Strategy - Boot Barn plans to continue opening stores at a rate of 15% annually, targeting a total of 524 to 529 stores by the end of the year [25] - Long-term potential to double store count to 900 based on previous studies [26] Customer Demographics and Sales Mix - Customer demographics have remained consistent, with no significant shift towards higher-income customers [22] - Online sales have decreased from 17% to 10% of total sales due to new store growth [22] Strategic Initiatives 1. **Store Growth**: Continuous expansion with a focus on both legacy and new markets [25][26] 2. **Same Store Sales**: Consistent positive comps, with broad-based growth across all merchandise categories [33][36] 3. **Omnichannel Strategy**: Emphasis on in-store experiences while maintaining a digital presence [41] 4. **Exclusive Brands**: Focus on growing exclusive brands, which account for 35% of sales [46] Marketing and Brand Partnerships - Marketing budget has increased to $65 million, focusing on distribution and brand partnerships [38][39] - Collaborations with country music artists and events to enhance brand visibility [37] Future Growth Potential - Projected future sales growth of $1.4 billion from new stores, alongside comp sales [50] - Opportunities for margin expansion through full-price selling and supply chain efficiencies [51] Conclusion - Boot Barn is positioned for significant growth through strategic store expansion, consistent customer engagement, and a focus on exclusive brands, with a strong financial performance backing its initiatives [51]